McKesson Total Liabilities and Share Holders Equity 2010-2024 | MCK
McKesson total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- McKesson total liabilities and share holders equity for the quarter ending September 30, 2024 was $72.429B, a 9.59% increase year-over-year.
- McKesson total liabilities and share holders equity for 2024 was $67.443B, a 8.22% increase from 2023.
- McKesson total liabilities and share holders equity for 2023 was $62.32B, a 1.55% decline from 2022.
- McKesson total liabilities and share holders equity for 2022 was $63.298B, a 2.64% decline from 2021.
McKesson Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024 |
$67,443 |
| 2023 |
$62,320 |
| 2022 |
$63,298 |
| 2021 |
$65,015 |
| 2020 |
$61,247 |
| 2019 |
$59,672 |
| 2018 |
$60,381 |
| 2017 |
$60,969 |
| 2016 |
$56,523 |
| 2015 |
$53,870 |
| 2014 |
$51,759 |
| 2013 |
$34,786 |
| 2012 |
$33,093 |
| 2011 |
$30,886 |
| 2010 |
$28,189 |
| 2009 |
$25,267 |
McKesson Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-09-30 |
$72,429 |
| 2024-06-30 |
$71,670 |
| 2024-03-31 |
$67,443 |
| 2023-12-31 |
$66,512 |
| 2023-09-30 |
$66,091 |
| 2023-06-30 |
$64,096 |
| 2023-03-31 |
$62,320 |
| 2022-12-31 |
$62,690 |
| 2022-09-30 |
$63,081 |
| 2022-06-30 |
$62,295 |
| 2022-03-31 |
$63,298 |
| 2021-12-31 |
$63,708 |
| 2021-09-30 |
$63,601 |
| 2021-06-30 |
$62,894 |
| 2021-03-31 |
$65,015 |
| 2020-12-31 |
$61,845 |
| 2020-09-30 |
$61,558 |
| 2020-06-30 |
$57,666 |
| 2020-03-31 |
$61,247 |
| 2019-12-31 |
$60,873 |
| 2019-09-30 |
$58,994 |
| 2019-06-30 |
$61,680 |
| 2019-03-31 |
$59,672 |
| 2018-12-31 |
$61,011 |
| 2018-09-30 |
$61,421 |
| 2018-06-30 |
$61,282 |
| 2018-03-31 |
$60,381 |
| 2017-12-31 |
$64,213 |
| 2017-09-30 |
$63,846 |
| 2017-06-30 |
$61,816 |
| 2017-03-31 |
$60,969 |
| 2016-12-31 |
$57,874 |
| 2016-09-30 |
$58,315 |
| 2016-06-30 |
$57,904 |
| 2016-03-31 |
$56,523 |
| 2015-12-31 |
$55,087 |
| 2015-09-30 |
$55,819 |
| 2015-06-30 |
$55,925 |
| 2015-03-31 |
$53,870 |
| 2014-12-31 |
$55,110 |
| 2014-09-30 |
$52,232 |
| 2014-06-30 |
$53,006 |
| 2014-03-31 |
$51,759 |
| 2013-12-31 |
$36,479 |
| 2013-09-30 |
$35,947 |
| 2013-06-30 |
$35,491 |
| 2013-03-31 |
$34,786 |
| 2012-12-31 |
$33,433 |
| 2012-09-30 |
$32,968 |
| 2012-06-30 |
$31,748 |
| 2012-03-31 |
$33,093 |
| 2011-12-31 |
$33,157 |
| 2011-09-30 |
$31,907 |
| 2011-06-30 |
$31,017 |
| 2011-03-31 |
$30,886 |
| 2010-12-31 |
$30,396 |
| 2010-09-30 |
$26,792 |
| 2010-06-30 |
$27,399 |
| 2010-03-31 |
$28,189 |
| 2009-12-31 |
$27,539 |
| 2009-09-30 |
$26,624 |
| 2009-06-30 |
$25,717 |
| 2009-03-31 |
$25,267 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$79.753B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
